Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 7674879
Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof
granted -
US 7674923
Process for preparing forms of atorvastatin calcium substantially free of impurities
granted -
US 7674953
Method for producing transgenic plants with increased yield, comprising expressing of haemoglobin from Arabidopsis
granted -
US 7674935
Crystal forms of O-desmethylvenlafaxine
granted -
US 7674480
Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
granted -
US 7674249
Gels with predetermined conductivity used in electroporation of tissue
granted -
US 7674787
Conformationally constrained Smac mimetics and the uses thereof
granted -
US 7674779
RNAi modulation of MLL-AF4 and uses thereof
granted -
US 7674778
Oligonucleotides comprising a conjugate group linked through a C5-modified pyrimidine
granted -
US 7674777
Immunostimulatory nucleic acid molecules
granted -
US 7671071
Polymorphic Form XVI of fexofenadine hydrochloride
granted -
US 7670599
YKL-40 as a marker and prognostic indicator for cancers
granted -
US 7670600
Molecules with extended half-lives, compositions and uses thereof
granted -
US 7671221
Modulators of ATP-Binding Cassette transporters
granted -
US 7671198
Process for preparing intermediates to 5-HT4 receptor agonist compounds
granted -
US 7670806
ADP-ribosyl acceptor hydrolase 3 (ARH3) polypeptides and methods of use
granted -
US 7670767
Genetic alterations associated with cancer
granted -
US 7671174
Ligand to GPR8
granted -
US 7670855
Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
granted -
US 7671058
N-(3,4-disubstituted phenyl) salicylamide derivatives
granted -
US 7666867
Heteroindanes: a new class of potent cannabimimetic ligands
granted -
US 7666889
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
granted -
US 7666886
Compounds and methods for the diagnosis and treatment of amyloid associated diseases
granted -
US 7666581
Methods for preparing compositions comprising heat shock proteins useful for the treatment of cancer and infectious disease
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.